A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
John Y. Li(Altimmune (United States)), Samuel R. Perry, Vanessa Muniz‐Medina, Xinzhong Wang, Leslie Wetzel, Marlon C. Rebelatto, Mary Jane Hinrichs, Binyam Bezabeh, Ryan Fleming, Nazzareno Dimasi, Hui Feng, Dorin Toader, Andy Q. Yuan, Lan Xu, Jia Lin, Changshou Gao, Herren Wu, Rakesh Dixit, Jane Osbourn(Adaptimmune (United Kingdom)), Steven Coats
Cited by 387Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis